Geographic Atrophy

Severe geographic atrophy at baseline leads to higher outpatient costs

Posted on

Patients who had more severe geographic atrophy (GA) at baseline had greater healthcare resource utilization (HCRU) and outpatient costs, according to a study.

In this retrospective analysis, disease-specific HCRU and costs by disease severity were assessed for 28,773 patients with GA; 24% of patients had unilateral GA and 76% had bilateral GA.

Patients in the bilateral group with greater baseline severity had a significantly higher number of outpatient (OP) visits per year.

In the outpatient setting, higher patient-related costs were associated with increasing disease severity, and higher payer-related costs were seen in patients with bilateral GA without subfoveal involvement compared to bilateral early or intermediate AMD ($280 vs $198).

The authors concluded that “Further research should explore specific contributing factors to the long-term economic burden of GA.”

Kim A, Devine B, Campbell J, et al. Healthcare resource utilization and costs in patients with geographic atrophy secondary to age-related macular degeneration. Clin Ophthalmol. 2021;15:2643-2651. https://doi.org/10.2147/OPTH.S307603

This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.

Related Articles
Wearable collision warning device helps visually impaired individuals
Jul 22, 2021
Psoriasis linked with significantly higher risk of retinal diseases
Jul 20, 2021
Ranibizumab biosimilar has comparable efficacy, safety profile to reference product in patients with nAMD
Jul 19, 2021